1 | <?xml version="1.0" encoding="UTF-8"?>
|
---|
2 | <!-- edited with XMLSpy v2010 rel. 2 (http://www.altova.com) by Len Gallagher (NIST) -->
|
---|
3 | <ccr:ContinuityOfCareRecord xsi:schemaLocation="urn:astm-org:CCR CCRV1.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ccr="urn:astm-org:CCR">
|
---|
4 | <ccr:CCRDocumentObjectID>CCR_AMBv11_DS01</ccr:CCRDocumentObjectID>
|
---|
5 | <ccr:Language>
|
---|
6 | <ccr:Text>US English</ccr:Text>
|
---|
7 | <ccr:Code>
|
---|
8 | <ccr:Value>en-US</ccr:Value>
|
---|
9 | </ccr:Code>
|
---|
10 | </ccr:Language>
|
---|
11 | <ccr:Version>V1.0</ccr:Version>
|
---|
12 | <ccr:DateTime>
|
---|
13 | <ccr:ExactDateTime>2010-03-25T13:15:00-05:00</ccr:ExactDateTime>
|
---|
14 | </ccr:DateTime>
|
---|
15 | <ccr:Patient>
|
---|
16 | <ccr:ActorID>PatientID_1</ccr:ActorID>
|
---|
17 | </ccr:Patient>
|
---|
18 | <ccr:From>
|
---|
19 | <ccr:ActorLink>
|
---|
20 | <ccr:ActorID>AuthorID_01</ccr:ActorID>
|
---|
21 | <ccr:ActorRole>
|
---|
22 | <ccr:Text>Personal Physician</ccr:Text>
|
---|
23 | </ccr:ActorRole>
|
---|
24 | </ccr:ActorLink>
|
---|
25 | </ccr:From>
|
---|
26 | <ccr:To>
|
---|
27 | <ccr:ActorLink>
|
---|
28 | <ccr:ActorID>RecipientID_01</ccr:ActorID>
|
---|
29 | <ccr:ActorRole>
|
---|
30 | <ccr:Text>Interested Party</ccr:Text>
|
---|
31 | </ccr:ActorRole>
|
---|
32 | </ccr:ActorLink>
|
---|
33 | </ccr:To>
|
---|
34 | <ccr:Purpose>
|
---|
35 | <ccr:Description>
|
---|
36 | <ccr:Text>Transfer of Care</ccr:Text>
|
---|
37 | </ccr:Description>
|
---|
38 | </ccr:Purpose>
|
---|
39 | <ccr:Body>
|
---|
40 | <ccr:Problems>
|
---|
41 |
|
---|
42 |
|
---|
43 | <ccr:Problem>
|
---|
44 | <ccr:CCRDataObjectID>ProbID_1</ccr:CCRDataObjectID>
|
---|
45 | <ccr:DateTime>
|
---|
46 | <ccr:ApproximateDateTime>
|
---|
47 | <ccr:Text>09/16/2009</ccr:Text>
|
---|
48 | </ccr:ApproximateDateTime>
|
---|
49 | </ccr:DateTime>
|
---|
50 | <ccr:Type>
|
---|
51 | <ccr:Text>Finding</ccr:Text>
|
---|
52 | </ccr:Type>
|
---|
53 | <ccr:Description>
|
---|
54 | <ccr:Text>Diabetes Mellitus, Type 2</ccr:Text>
|
---|
55 | <ccr:Code>
|
---|
56 | <ccr:Value>250.02</ccr:Value>
|
---|
57 | <ccr:CodingSystem>ICD9-CM</ccr:CodingSystem>
|
---|
58 | </ccr:Code>
|
---|
59 | <ccr:Code>
|
---|
60 | <ccr:Value>44054006</ccr:Value>
|
---|
61 | <ccr:CodingSystem>SNOMED CT</ccr:CodingSystem>
|
---|
62 | </ccr:Code>
|
---|
63 | </ccr:Description>
|
---|
64 | <ccr:Status>
|
---|
65 | <ccr:Text>Active</ccr:Text>
|
---|
66 | </ccr:Status>
|
---|
67 | <ccr:Source>
|
---|
68 | <ccr:Actor>
|
---|
69 | <ccr:ActorID>AuthorID_01</ccr:ActorID>
|
---|
70 | </ccr:Actor>
|
---|
71 | </ccr:Source>
|
---|
72 | </ccr:Problem>
|
---|
73 | <ccr:Problem>
|
---|
74 | <ccr:CCRDataObjectID>ProbID_2</ccr:CCRDataObjectID>
|
---|
75 | <ccr:DateTime>
|
---|
76 | <ccr:ApproximateDateTime>
|
---|
77 | <ccr:Text>05/05/2002</ccr:Text>
|
---|
78 | </ccr:ApproximateDateTime>
|
---|
79 | </ccr:DateTime>
|
---|
80 | <ccr:Type>
|
---|
81 | <ccr:Text>Symptom</ccr:Text>
|
---|
82 | </ccr:Type>
|
---|
83 | <ccr:Description>
|
---|
84 | <ccr:Text>Hyperlipidemia</ccr:Text>
|
---|
85 | <ccr:Code>
|
---|
86 | <ccr:Value>272.4</ccr:Value>
|
---|
87 | <ccr:CodingSystem>ICD9-CM</ccr:CodingSystem>
|
---|
88 | </ccr:Code>
|
---|
89 | <ccr:Code>
|
---|
90 | <ccr:Value>55822004</ccr:Value>
|
---|
91 | <ccr:CodingSystem>SNOMED CT</ccr:CodingSystem>
|
---|
92 | </ccr:Code>
|
---|
93 | </ccr:Description>
|
---|
94 | <ccr:Status>
|
---|
95 | <ccr:Text>Active</ccr:Text>
|
---|
96 | </ccr:Status>
|
---|
97 | <ccr:Source>
|
---|
98 | <ccr:Actor>
|
---|
99 | <ccr:ActorID>AuthorID_01</ccr:ActorID>
|
---|
100 | </ccr:Actor>
|
---|
101 | </ccr:Source>
|
---|
102 | </ccr:Problem>
|
---|
103 | <ccr:Problem>
|
---|
104 | <ccr:CCRDataObjectID>ProbID_3</ccr:CCRDataObjectID>
|
---|
105 | <ccr:DateTime>
|
---|
106 | <ccr:ApproximateDateTime>
|
---|
107 | <ccr:Text>05/05/2002</ccr:Text>
|
---|
108 | </ccr:ApproximateDateTime>
|
---|
109 | </ccr:DateTime>
|
---|
110 | <ccr:Type>
|
---|
111 | <ccr:Text>Finding</ccr:Text>
|
---|
112 | </ccr:Type>
|
---|
113 | <ccr:Description>
|
---|
114 | <ccr:Text>Coronary Artery Disease (CAD)</ccr:Text>
|
---|
115 | <ccr:Code>
|
---|
116 | <ccr:Value>414.01</ccr:Value>
|
---|
117 | <ccr:CodingSystem>ICD9-CM</ccr:CodingSystem>
|
---|
118 | </ccr:Code>
|
---|
119 | <ccr:Code>
|
---|
120 | <ccr:Value>53741008</ccr:Value>
|
---|
121 | <ccr:CodingSystem>SNOMED CT</ccr:CodingSystem>
|
---|
122 | </ccr:Code>
|
---|
123 | </ccr:Description>
|
---|
124 | <ccr:Status>
|
---|
125 | <ccr:Text>Chronic</ccr:Text>
|
---|
126 | </ccr:Status>
|
---|
127 | <ccr:Source>
|
---|
128 | <ccr:Actor>
|
---|
129 | <ccr:ActorID>AuthorID_01</ccr:ActorID>
|
---|
130 | </ccr:Actor>
|
---|
131 | </ccr:Source>
|
---|
132 | </ccr:Problem>
|
---|
133 | <ccr:Problem>
|
---|
134 | <ccr:CCRDataObjectID>ProbID_4</ccr:CCRDataObjectID>
|
---|
135 | <ccr:DateTime>
|
---|
136 | <ccr:ApproximateDateTime>
|
---|
137 | <ccr:Text>05/05/2002</ccr:Text>
|
---|
138 | </ccr:ApproximateDateTime>
|
---|
139 | </ccr:DateTime>
|
---|
140 | <ccr:Type>
|
---|
141 | <ccr:Text>Diagnosis</ccr:Text>
|
---|
142 | </ccr:Type>
|
---|
143 | <ccr:Description>
|
---|
144 | <ccr:Text>Hypertension, Essential</ccr:Text>
|
---|
145 | <ccr:Code>
|
---|
146 | <ccr:Value>401.9</ccr:Value>
|
---|
147 | <ccr:CodingSystem>ICD9-CM</ccr:CodingSystem>
|
---|
148 | </ccr:Code>
|
---|
149 | <ccr:Code>
|
---|
150 | <ccr:Value>59621000</ccr:Value>
|
---|
151 | <ccr:CodingSystem>SNOMED CT</ccr:CodingSystem>
|
---|
152 | </ccr:Code>
|
---|
153 | </ccr:Description>
|
---|
154 | <ccr:Status>
|
---|
155 | <ccr:Text>Active</ccr:Text>
|
---|
156 | </ccr:Status>
|
---|
157 | <ccr:Source>
|
---|
158 | <ccr:Actor>
|
---|
159 | <ccr:ActorID>AuthorID_01</ccr:ActorID>
|
---|
160 | </ccr:Actor>
|
---|
161 | </ccr:Source>
|
---|
162 | </ccr:Problem>
|
---|
163 |
|
---|
164 | </ccr:Problems>
|
---|
165 |
|
---|
166 | <ccr:Alerts>
|
---|
167 | <ccr:Alert>
|
---|
168 | <ccr:CCRDataObjectID>AlertID_1</ccr:CCRDataObjectID>
|
---|
169 | <ccr:DateTime>
|
---|
170 | <ccr:ApproximateDateTime>
|
---|
171 | <ccr:Text>6/27/02</ccr:Text>
|
---|
172 | </ccr:ApproximateDateTime>
|
---|
173 | </ccr:DateTime>
|
---|
174 | <ccr:Type>
|
---|
175 | <ccr:Text>Drug Allergy</ccr:Text>
|
---|
176 | <ccr:Code>
|
---|
177 | <ccr:Value>416098002</ccr:Value>
|
---|
178 | <ccr:CodingSystem>SNOMED CT</ccr:CodingSystem>
|
---|
179 | </ccr:Code>
|
---|
180 | </ccr:Type>
|
---|
181 | <ccr:Description>
|
---|
182 | <ccr:Text>Codeine allergy</ccr:Text>
|
---|
183 | <ccr:Code>
|
---|
184 | <ccr:Value>293597001</ccr:Value>
|
---|
185 | <ccr:CodingSystem>SNOMED CT</ccr:CodingSystem>
|
---|
186 | </ccr:Code>
|
---|
187 | </ccr:Description>
|
---|
188 | <ccr:Status>
|
---|
189 | <ccr:Text>Active</ccr:Text>
|
---|
190 | </ccr:Status>
|
---|
191 | <ccr:Source>
|
---|
192 | <ccr:Actor>
|
---|
193 | <ccr:ActorID>AuthorID_01</ccr:ActorID>
|
---|
194 | </ccr:Actor>
|
---|
195 | </ccr:Source>
|
---|
196 | <ccr:Agent>
|
---|
197 | <ccr:Products>
|
---|
198 | <ccr:Product>
|
---|
199 | <ccr:CCRDataObjectID/>
|
---|
200 | <ccr:Source/>
|
---|
201 | <ccr:Product>
|
---|
202 | <ccr:ProductName>
|
---|
203 | <ccr:Text>Codeine</ccr:Text>
|
---|
204 | <ccr:Code>
|
---|
205 | <ccr:Value>2670</ccr:Value>
|
---|
206 | <ccr:CodingSystem>RxNorm</ccr:CodingSystem>
|
---|
207 | </ccr:Code>
|
---|
208 | </ccr:ProductName>
|
---|
209 | </ccr:Product>
|
---|
210 | </ccr:Product>
|
---|
211 | </ccr:Products>
|
---|
212 | </ccr:Agent>
|
---|
213 | <ccr:Reaction>
|
---|
214 | <ccr:Description>
|
---|
215 | <ccr:Text>Hives, nausea</ccr:Text>
|
---|
216 | </ccr:Description>
|
---|
217 | </ccr:Reaction>
|
---|
218 | </ccr:Alert>
|
---|
219 |
|
---|
220 | <ccr:Alert>
|
---|
221 | <ccr:CCRDataObjectID>AlertID_2</ccr:CCRDataObjectID>
|
---|
222 | <ccr:DateTime>
|
---|
223 | <ccr:ApproximateDateTime>
|
---|
224 | <ccr:Text>3/25/04</ccr:Text>
|
---|
225 | </ccr:ApproximateDateTime>
|
---|
226 | </ccr:DateTime>
|
---|
227 | <ccr:Type>
|
---|
228 | <ccr:Text>Drug Allergy</ccr:Text>
|
---|
229 | <ccr:Code>
|
---|
230 | <ccr:Value>416098002</ccr:Value>
|
---|
231 | <ccr:CodingSystem>SNOMED CT</ccr:CodingSystem>
|
---|
232 | </ccr:Code>
|
---|
233 | </ccr:Type>
|
---|
234 | <ccr:Description>
|
---|
235 | <ccr:Text>Indomethacin allergy</ccr:Text>
|
---|
236 | <ccr:Code>
|
---|
237 | <ccr:Value>293620004</ccr:Value>
|
---|
238 | <ccr:CodingSystem>SNOMED CT</ccr:CodingSystem>
|
---|
239 | </ccr:Code>
|
---|
240 | </ccr:Description>
|
---|
241 | <ccr:Status>
|
---|
242 | <ccr:Text>Active</ccr:Text>
|
---|
243 | </ccr:Status>
|
---|
244 | <ccr:Source>
|
---|
245 | <ccr:Actor>
|
---|
246 | <ccr:ActorID>AuthorID_01</ccr:ActorID>
|
---|
247 | </ccr:Actor>
|
---|
248 | </ccr:Source>
|
---|
249 | <ccr:Reaction>
|
---|
250 | <ccr:Description>
|
---|
251 | <ccr:Text>Nausea, dizziness, headache</ccr:Text>
|
---|
252 | </ccr:Description>
|
---|
253 | </ccr:Reaction>
|
---|
254 | </ccr:Alert>
|
---|
255 | </ccr:Alerts>
|
---|
256 |
|
---|
257 | <ccr:Medications>
|
---|
258 |
|
---|
259 | <ccr:Medication>
|
---|
260 | <ccr:CCRDataObjectID>MedID_01</ccr:CCRDataObjectID>
|
---|
261 | <ccr:DateTime>
|
---|
262 | <ccr:ApproximateDateTime>
|
---|
263 | <ccr:Text>09/16/2009</ccr:Text>
|
---|
264 | </ccr:ApproximateDateTime>
|
---|
265 | </ccr:DateTime>
|
---|
266 | <ccr:Status>
|
---|
267 | <ccr:Text>Active</ccr:Text>
|
---|
268 | </ccr:Status>
|
---|
269 | <ccr:Source>
|
---|
270 | <ccr:Actor>
|
---|
271 | <ccr:ActorID>AuthorID_01</ccr:ActorID>
|
---|
272 | </ccr:Actor>
|
---|
273 | </ccr:Source>
|
---|
274 | <ccr:Product>
|
---|
275 | <ccr:ProductName>
|
---|
276 | <ccr:Text>glyburide</ccr:Text>
|
---|
277 | <ccr:Code>
|
---|
278 | <ccr:Value>205875</ccr:Value>
|
---|
279 | <ccr:CodingSystem>RxNorm</ccr:CodingSystem>
|
---|
280 | </ccr:Code>
|
---|
281 | </ccr:ProductName>
|
---|
282 | <ccr:BrandName>
|
---|
283 | <ccr:Text>Diabeta</ccr:Text>
|
---|
284 | </ccr:BrandName>
|
---|
285 | <ccr:Strength>
|
---|
286 | <ccr:Value>2.5</ccr:Value>
|
---|
287 | <ccr:Units>
|
---|
288 | <ccr:Unit>mg</ccr:Unit>
|
---|
289 | </ccr:Units>
|
---|
290 | </ccr:Strength>
|
---|
291 | <ccr:Form>
|
---|
292 | <ccr:Text>Tablet</ccr:Text>
|
---|
293 | </ccr:Form>
|
---|
294 | </ccr:Product>
|
---|
295 | <ccr:Directions>
|
---|
296 | <ccr:Direction>
|
---|
297 | <ccr:Frequency>
|
---|
298 | <ccr:Value>1 tab Q AM PO</ccr:Value>
|
---|
299 | </ccr:Frequency>
|
---|
300 | </ccr:Direction>
|
---|
301 | </ccr:Directions>
|
---|
302 | <ccr:PatientInstructions>
|
---|
303 | <ccr:Instruction>
|
---|
304 | <ccr:Text>1 tablet by mouth every morning</ccr:Text>
|
---|
305 | </ccr:Instruction>
|
---|
306 | </ccr:PatientInstructions>
|
---|
307 | </ccr:Medication>
|
---|
308 |
|
---|
309 | <ccr:Medication>
|
---|
310 | <ccr:CCRDataObjectID>MedID_02</ccr:CCRDataObjectID>
|
---|
311 | <ccr:DateTime>
|
---|
312 | <ccr:ApproximateDateTime>
|
---|
313 | <ccr:Text>05/05/2002</ccr:Text>
|
---|
314 | </ccr:ApproximateDateTime>
|
---|
315 | </ccr:DateTime>
|
---|
316 | <ccr:Status>
|
---|
317 | <ccr:Text>Active</ccr:Text>
|
---|
318 | </ccr:Status>
|
---|
319 | <ccr:Source>
|
---|
320 | <ccr:Actor>
|
---|
321 | <ccr:ActorID>AuthorID_01</ccr:ActorID>
|
---|
322 | </ccr:Actor>
|
---|
323 | </ccr:Source>
|
---|
324 | <ccr:Product>
|
---|
325 | <ccr:ProductName>
|
---|
326 | <ccr:Text>atorvastatin calcium</ccr:Text>
|
---|
327 | <ccr:Code>
|
---|
328 | <ccr:Value>617314</ccr:Value>
|
---|
329 | <ccr:CodingSystem>RxNorm</ccr:CodingSystem>
|
---|
330 | </ccr:Code>
|
---|
331 | </ccr:ProductName>
|
---|
332 | <ccr:BrandName>
|
---|
333 | <ccr:Text>Lipitor</ccr:Text>
|
---|
334 | </ccr:BrandName>
|
---|
335 | <ccr:Strength>
|
---|
336 | <ccr:Value>10</ccr:Value>
|
---|
337 | <ccr:Units>
|
---|
338 | <ccr:Unit>mg</ccr:Unit>
|
---|
339 | </ccr:Units>
|
---|
340 | </ccr:Strength>
|
---|
341 | <ccr:Form>
|
---|
342 | <ccr:Text>Tablet</ccr:Text>
|
---|
343 | </ccr:Form>
|
---|
344 | </ccr:Product>
|
---|
345 | <ccr:Directions>
|
---|
346 | <ccr:Direction>
|
---|
347 | <ccr:Frequency>
|
---|
348 | <ccr:Value>1 tab Q Day PO</ccr:Value>
|
---|
349 | </ccr:Frequency>
|
---|
350 | </ccr:Direction>
|
---|
351 | </ccr:Directions>
|
---|
352 | <ccr:PatientInstructions>
|
---|
353 | <ccr:Instruction>
|
---|
354 | <ccr:Text>1 tablet by mouth every day</ccr:Text>
|
---|
355 | </ccr:Instruction>
|
---|
356 | </ccr:PatientInstructions>
|
---|
357 | </ccr:Medication>
|
---|
358 |
|
---|
359 | <ccr:Medication>
|
---|
360 | <ccr:CCRDataObjectID>MedID_03</ccr:CCRDataObjectID>
|
---|
361 | <ccr:DateTime>
|
---|
362 | <ccr:ApproximateDateTime>
|
---|
363 | <ccr:Text>05/05/2002</ccr:Text>
|
---|
364 | </ccr:ApproximateDateTime>
|
---|
365 | </ccr:DateTime>
|
---|
366 | <ccr:Status>
|
---|
367 | <ccr:Text>Active</ccr:Text>
|
---|
368 | </ccr:Status>
|
---|
369 | <ccr:Source>
|
---|
370 | <ccr:Actor>
|
---|
371 | <ccr:ActorID>AuthorID_01</ccr:ActorID>
|
---|
372 | </ccr:Actor>
|
---|
373 | </ccr:Source>
|
---|
374 | <ccr:Product>
|
---|
375 | <ccr:ProductName>
|
---|
376 | <ccr:Text>furosemide</ccr:Text>
|
---|
377 | <ccr:Code>
|
---|
378 | <ccr:Value>200801</ccr:Value>
|
---|
379 | <ccr:CodingSystem>RxNorm</ccr:CodingSystem>
|
---|
380 | </ccr:Code>
|
---|
381 | </ccr:ProductName>
|
---|
382 | <ccr:BrandName>
|
---|
383 | <ccr:Text>Lasix</ccr:Text>
|
---|
384 | </ccr:BrandName>
|
---|
385 | <ccr:Strength>
|
---|
386 | <ccr:Value>20</ccr:Value>
|
---|
387 | <ccr:Units>
|
---|
388 | <ccr:Unit>mg</ccr:Unit>
|
---|
389 | </ccr:Units>
|
---|
390 | </ccr:Strength>
|
---|
391 | <ccr:Form>
|
---|
392 | <ccr:Text>Tablet</ccr:Text>
|
---|
393 | </ccr:Form>
|
---|
394 | </ccr:Product>
|
---|
395 | <ccr:Directions>
|
---|
396 | <ccr:Direction>
|
---|
397 | <ccr:Frequency>
|
---|
398 | <ccr:Value>1 tab BID PO</ccr:Value>
|
---|
399 | </ccr:Frequency>
|
---|
400 | </ccr:Direction>
|
---|
401 | </ccr:Directions>
|
---|
402 | <ccr:PatientInstructions>
|
---|
403 | <ccr:Instruction>
|
---|
404 | <ccr:Text>1 tablet by mouth 2 times per day</ccr:Text>
|
---|
405 | </ccr:Instruction>
|
---|
406 | </ccr:PatientInstructions>
|
---|
407 | </ccr:Medication>
|
---|
408 |
|
---|
409 | <ccr:Medication>
|
---|
410 | <ccr:CCRDataObjectID>MedID_04</ccr:CCRDataObjectID>
|
---|
411 | <ccr:DateTime>
|
---|
412 | <ccr:ApproximateDateTime>
|
---|
413 | <ccr:Text>05/05/2002</ccr:Text>
|
---|
414 | </ccr:ApproximateDateTime>
|
---|
415 | </ccr:DateTime>
|
---|
416 | <ccr:Status>
|
---|
417 | <ccr:Text>Active</ccr:Text>
|
---|
418 | </ccr:Status>
|
---|
419 | <ccr:Source>
|
---|
420 | <ccr:Actor>
|
---|
421 | <ccr:ActorID>AuthorID_01</ccr:ActorID>
|
---|
422 | </ccr:Actor>
|
---|
423 | </ccr:Source>
|
---|
424 | <ccr:Product>
|
---|
425 | <ccr:ProductName>
|
---|
426 | <ccr:Text>potassium chloride</ccr:Text>
|
---|
427 | <ccr:Code>
|
---|
428 | <ccr:Value>628958</ccr:Value>
|
---|
429 | <ccr:CodingSystem>RxNorm</ccr:CodingSystem>
|
---|
430 | </ccr:Code>
|
---|
431 | </ccr:ProductName>
|
---|
432 | <ccr:BrandName>
|
---|
433 | <ccr:Text>Klor-Con</ccr:Text>
|
---|
434 | </ccr:BrandName>
|
---|
435 | <ccr:Strength>
|
---|
436 | <ccr:Value>10</ccr:Value>
|
---|
437 | <ccr:Units>
|
---|
438 | <ccr:Unit>mEq</ccr:Unit>
|
---|
439 | </ccr:Units>
|
---|
440 | </ccr:Strength>
|
---|
441 | <ccr:Form>
|
---|
442 | <ccr:Text>Tablet</ccr:Text>
|
---|
443 | </ccr:Form>
|
---|
444 | </ccr:Product>
|
---|
445 | <ccr:Directions>
|
---|
446 | <ccr:Direction>
|
---|
447 | <ccr:Frequency>
|
---|
448 | <ccr:Value>1 tab BID PO</ccr:Value>
|
---|
449 | </ccr:Frequency>
|
---|
450 | </ccr:Direction>
|
---|
451 | </ccr:Directions>
|
---|
452 | <ccr:PatientInstructions>
|
---|
453 | <ccr:Instruction>
|
---|
454 | <ccr:Text>1 tablet by mouth 2 times per day</ccr:Text>
|
---|
455 | </ccr:Instruction>
|
---|
456 | </ccr:PatientInstructions>
|
---|
457 | </ccr:Medication>
|
---|
458 |
|
---|
459 |
|
---|
460 | </ccr:Medications>
|
---|
461 |
|
---|
462 |
|
---|
463 | <ccr:Immunizations>
|
---|
464 | <ccr:Immunization>
|
---|
465 | <ccr:CCRDataObjectID>ImmunizID_01</ccr:CCRDataObjectID>
|
---|
466 | <ccr:DateTime>
|
---|
467 | <ccr:ApproximateDateTime>
|
---|
468 | <ccr:Text>03/25/2010</ccr:Text>
|
---|
469 | </ccr:ApproximateDateTime>
|
---|
470 | </ccr:DateTime>
|
---|
471 | <ccr:Source>
|
---|
472 | <ccr:Actor>
|
---|
473 | <ccr:ActorID>AuthorID_01</ccr:ActorID>
|
---|
474 | </ccr:Actor>
|
---|
475 | </ccr:Source>
|
---|
476 | <ccr:Product>
|
---|
477 | <ccr:ProductName>
|
---|
478 | <ccr:Text>Hepatitis A, Adult</ccr:Text>
|
---|
479 | <ccr:Code>
|
---|
480 | <ccr:Value>52</ccr:Value>
|
---|
481 | <ccr:CodingSystem>CVX</ccr:CodingSystem>
|
---|
482 | </ccr:Code>
|
---|
483 | <ccr:Code>
|
---|
484 | <ccr:Value>798367</ccr:Value>
|
---|
485 | <ccr:CodingSystem>RxNorm</ccr:CodingSystem>
|
---|
486 | </ccr:Code>
|
---|
487 | </ccr:ProductName>
|
---|
488 | <ccr:Manufacturer>
|
---|
489 | <ccr:ActorID>ManufID_1</ccr:ActorID>
|
---|
490 | <ccr:ActorRole>
|
---|
491 | <ccr:Text>GLAXOSMITHKLINE</ccr:Text>
|
---|
492 | </ccr:ActorRole>
|
---|
493 | </ccr:Manufacturer>
|
---|
494 | </ccr:Product>
|
---|
495 | <ccr:Directions>
|
---|
496 | <ccr:Direction>
|
---|
497 | <ccr:Route>
|
---|
498 | <ccr:Text>Intramuscular</ccr:Text>
|
---|
499 | <ccr:Code>
|
---|
500 | <ccr:Value>IM</ccr:Value>
|
---|
501 | </ccr:Code>
|
---|
502 | </ccr:Route>
|
---|
503 | <ccr:Site>
|
---|
504 | <ccr:Text>Left Arm</ccr:Text>
|
---|
505 | </ccr:Site>
|
---|
506 | </ccr:Direction>
|
---|
507 | </ccr:Directions>
|
---|
508 | <ccr:SeriesNumber>HA165V1</ccr:SeriesNumber>
|
---|
509 | <ccr:Reaction>
|
---|
510 | <ccr:Description>
|
---|
511 | <ccr:Text>None</ccr:Text>
|
---|
512 | </ccr:Description>
|
---|
513 | </ccr:Reaction>
|
---|
514 | </ccr:Immunization>
|
---|
515 | <ccr:Immunization>
|
---|
516 | <ccr:CCRDataObjectID>ImmunizID_02</ccr:CCRDataObjectID>
|
---|
517 | <ccr:DateTime>
|
---|
518 | <ccr:ApproximateDateTime>
|
---|
519 | <ccr:Text>10/25/2009</ccr:Text>
|
---|
520 | </ccr:ApproximateDateTime>
|
---|
521 | </ccr:DateTime>
|
---|
522 | <ccr:Source>
|
---|
523 | <ccr:Actor>
|
---|
524 | <ccr:ActorID>AuthorID_01</ccr:ActorID>
|
---|
525 | </ccr:Actor>
|
---|
526 | </ccr:Source>
|
---|
527 | <ccr:Product>
|
---|
528 | <ccr:ProductName>
|
---|
529 | <ccr:Text>Pneumococcal Polysaccharide Vaccine</ccr:Text>
|
---|
530 | <ccr:Code>
|
---|
531 | <ccr:Value>33</ccr:Value>
|
---|
532 | <ccr:CodingSystem>CVX</ccr:CodingSystem>
|
---|
533 | </ccr:Code>
|
---|
534 | <ccr:Code>
|
---|
535 | <ccr:Value>854977</ccr:Value>
|
---|
536 | <ccr:CodingSystem>RxNorm</ccr:CodingSystem>
|
---|
537 | </ccr:Code>
|
---|
538 | </ccr:ProductName>
|
---|
539 | <ccr:Manufacturer>
|
---|
540 | <ccr:ActorID>ManufID_2</ccr:ActorID>
|
---|
541 | <ccr:ActorRole>
|
---|
542 | <ccr:Text>Merck</ccr:Text>
|
---|
543 | </ccr:ActorRole>
|
---|
544 | </ccr:Manufacturer>
|
---|
545 | </ccr:Product>
|
---|
546 | <ccr:Directions>
|
---|
547 | <ccr:Direction>
|
---|
548 | <ccr:Route>
|
---|
549 | <ccr:Text>Intramuscular</ccr:Text>
|
---|
550 | <ccr:Code>
|
---|
551 | <ccr:Value>IM</ccr:Value>
|
---|
552 | </ccr:Code>
|
---|
553 | </ccr:Route>
|
---|
554 | <ccr:Site>
|
---|
555 | <ccr:Text>Right Arm</ccr:Text>
|
---|
556 | </ccr:Site>
|
---|
557 | </ccr:Direction>
|
---|
558 | </ccr:Directions>
|
---|
559 | <ccr:SeriesNumber>887765B</ccr:SeriesNumber>
|
---|
560 | <ccr:Reaction>
|
---|
561 | <ccr:Description>
|
---|
562 | <ccr:Text>None</ccr:Text>
|
---|
563 | </ccr:Description>
|
---|
564 | </ccr:Reaction>
|
---|
565 | </ccr:Immunization>
|
---|
566 | </ccr:Immunizations>
|
---|
567 |
|
---|
568 | <ccr:Results>
|
---|
569 | <ccr:Result>
|
---|
570 | <ccr:CCRDataObjectID>ResultID_01</ccr:CCRDataObjectID>
|
---|
571 | <ccr:DateTime>
|
---|
572 | <ccr:ApproximateDateTime>
|
---|
573 | <ccr:Text>9/16/09</ccr:Text>
|
---|
574 | </ccr:ApproximateDateTime>
|
---|
575 | </ccr:DateTime>
|
---|
576 | <ccr:Type>
|
---|
577 | <ccr:Text>Chemistry</ccr:Text>
|
---|
578 | </ccr:Type>
|
---|
579 | <ccr:Description>
|
---|
580 | <ccr:Text>Fasting Blood Glucose</ccr:Text>
|
---|
581 | <ccr:Code>
|
---|
582 | <ccr:Value>14771-0</ccr:Value>
|
---|
583 | <ccr:CodingSystem>LOINC</ccr:CodingSystem>
|
---|
584 | </ccr:Code>
|
---|
585 | </ccr:Description>
|
---|
586 | <ccr:Source>
|
---|
587 | <ccr:Actor>
|
---|
588 | <ccr:ActorID>AuthorID_01</ccr:ActorID>
|
---|
589 | </ccr:Actor>
|
---|
590 | </ccr:Source>
|
---|
591 | <ccr:Test>
|
---|
592 | <ccr:CCRDataObjectID/>
|
---|
593 | <ccr:Description>
|
---|
594 | <ccr:Text>Fasting Blood Glucose</ccr:Text>
|
---|
595 | <ccr:Code>
|
---|
596 | <ccr:Value>14771-0</ccr:Value>
|
---|
597 | <ccr:CodingSystem>LOINC</ccr:CodingSystem>
|
---|
598 | </ccr:Code>
|
---|
599 | </ccr:Description>
|
---|
600 | <ccr:Status>
|
---|
601 | <ccr:Text>final result</ccr:Text>
|
---|
602 | </ccr:Status>
|
---|
603 | <ccr:Source/>
|
---|
604 | <ccr:TestResult>
|
---|
605 | <ccr:Value>178</ccr:Value>
|
---|
606 | <ccr:Units>
|
---|
607 | <ccr:Unit>mg/dl</ccr:Unit>
|
---|
608 | </ccr:Units>
|
---|
609 | </ccr:TestResult>
|
---|
610 | <ccr:NormalResult>
|
---|
611 | <ccr:Normal>
|
---|
612 | <ccr:Value>70-100</ccr:Value>
|
---|
613 | <ccr:Units>
|
---|
614 | <ccr:Unit>mg/dl</ccr:Unit>
|
---|
615 | </ccr:Units>
|
---|
616 | <ccr:Source/>
|
---|
617 | </ccr:Normal>
|
---|
618 | </ccr:NormalResult>
|
---|
619 | </ccr:Test>
|
---|
620 | </ccr:Result>
|
---|
621 |
|
---|
622 | <ccr:Result>
|
---|
623 | <ccr:CCRDataObjectID>ResultID_02</ccr:CCRDataObjectID>
|
---|
624 | <ccr:DateTime>
|
---|
625 | <ccr:ApproximateDateTime>
|
---|
626 | <ccr:Text>9/16/09</ccr:Text>
|
---|
627 | </ccr:ApproximateDateTime>
|
---|
628 | </ccr:DateTime>
|
---|
629 | <ccr:Type>
|
---|
630 | <ccr:Text>Chemistry</ccr:Text>
|
---|
631 | </ccr:Type>
|
---|
632 | <ccr:Description>
|
---|
633 | <ccr:Text>Creatinine</ccr:Text>
|
---|
634 | <ccr:Code>
|
---|
635 | <ccr:Value>14682-9</ccr:Value>
|
---|
636 | <ccr:CodingSystem>LOINC</ccr:CodingSystem>
|
---|
637 | </ccr:Code>
|
---|
638 | </ccr:Description>
|
---|
639 | <ccr:Source>
|
---|
640 | <ccr:Actor>
|
---|
641 | <ccr:ActorID>AuthorID_01</ccr:ActorID>
|
---|
642 | </ccr:Actor>
|
---|
643 | </ccr:Source>
|
---|
644 | <ccr:Test>
|
---|
645 | <ccr:CCRDataObjectID/>
|
---|
646 | <ccr:Description>
|
---|
647 | <ccr:Text>Creatinine</ccr:Text>
|
---|
648 | <ccr:Code>
|
---|
649 | <ccr:Value>14682-9</ccr:Value>
|
---|
650 | <ccr:CodingSystem>LOINC</ccr:CodingSystem>
|
---|
651 | </ccr:Code>
|
---|
652 | </ccr:Description>
|
---|
653 | <ccr:Status>
|
---|
654 | <ccr:Text>final result</ccr:Text>
|
---|
655 | </ccr:Status>
|
---|
656 | <ccr:Source/>
|
---|
657 | <ccr:TestResult>
|
---|
658 | <ccr:Value>1.0</ccr:Value>
|
---|
659 | <ccr:Units>
|
---|
660 | <ccr:Unit>mg/dl</ccr:Unit>
|
---|
661 | </ccr:Units>
|
---|
662 | </ccr:TestResult>
|
---|
663 | <ccr:NormalResult>
|
---|
664 | <ccr:Normal>
|
---|
665 | <ccr:Value>0.5-1.4</ccr:Value>
|
---|
666 | <ccr:Units>
|
---|
667 | <ccr:Unit>mg/dl</ccr:Unit>
|
---|
668 | </ccr:Units>
|
---|
669 | <ccr:Source/>
|
---|
670 | </ccr:Normal>
|
---|
671 | </ccr:NormalResult>
|
---|
672 | </ccr:Test>
|
---|
673 | </ccr:Result>
|
---|
674 |
|
---|
675 | <ccr:Result>
|
---|
676 | <ccr:CCRDataObjectID>ResultID_03</ccr:CCRDataObjectID>
|
---|
677 | <ccr:DateTime>
|
---|
678 | <ccr:ApproximateDateTime>
|
---|
679 | <ccr:Text>9/16/09</ccr:Text>
|
---|
680 | </ccr:ApproximateDateTime>
|
---|
681 | </ccr:DateTime>
|
---|
682 | <ccr:Type>
|
---|
683 | <ccr:Text>Chemistry</ccr:Text>
|
---|
684 | </ccr:Type>
|
---|
685 | <ccr:Description>
|
---|
686 | <ccr:Text>BUN</ccr:Text>
|
---|
687 | <ccr:Code>
|
---|
688 | <ccr:Value>14937-7</ccr:Value>
|
---|
689 | <ccr:CodingSystem>LOINC</ccr:CodingSystem>
|
---|
690 | </ccr:Code>
|
---|
691 | </ccr:Description>
|
---|
692 | <ccr:Source>
|
---|
693 | <ccr:Actor>
|
---|
694 | <ccr:ActorID>AuthorID_01</ccr:ActorID>
|
---|
695 | </ccr:Actor>
|
---|
696 | </ccr:Source>
|
---|
697 | <ccr:Test>
|
---|
698 | <ccr:CCRDataObjectID/>
|
---|
699 | <ccr:Description>
|
---|
700 | <ccr:Text>BUN</ccr:Text>
|
---|
701 | <ccr:Code>
|
---|
702 | <ccr:Value>14937-7</ccr:Value>
|
---|
703 | <ccr:CodingSystem>LOINC</ccr:CodingSystem>
|
---|
704 | </ccr:Code>
|
---|
705 | </ccr:Description>
|
---|
706 | <ccr:Status>
|
---|
707 | <ccr:Text>final result</ccr:Text>
|
---|
708 | </ccr:Status>
|
---|
709 | <ccr:Source/>
|
---|
710 | <ccr:TestResult>
|
---|
711 | <ccr:Value>18</ccr:Value>
|
---|
712 | <ccr:Units>
|
---|
713 | <ccr:Unit>mg/dl</ccr:Unit>
|
---|
714 | </ccr:Units>
|
---|
715 | </ccr:TestResult>
|
---|
716 | <ccr:NormalResult>
|
---|
717 | <ccr:Normal>
|
---|
718 | <ccr:Value>7-30</ccr:Value>
|
---|
719 | <ccr:Units>
|
---|
720 | <ccr:Unit>mg/dl</ccr:Unit>
|
---|
721 | </ccr:Units>
|
---|
722 | <ccr:Source/>
|
---|
723 | </ccr:Normal>
|
---|
724 | </ccr:NormalResult>
|
---|
725 | </ccr:Test>
|
---|
726 | </ccr:Result>
|
---|
727 |
|
---|
728 | <ccr:Result>
|
---|
729 | <ccr:CCRDataObjectID>ResultID_04</ccr:CCRDataObjectID>
|
---|
730 | <ccr:DateTime>
|
---|
731 | <ccr:ApproximateDateTime>
|
---|
732 | <ccr:Text>9/16/09</ccr:Text>
|
---|
733 | </ccr:ApproximateDateTime>
|
---|
734 | </ccr:DateTime>
|
---|
735 | <ccr:Type>
|
---|
736 | <ccr:Text>Chemistry</ccr:Text>
|
---|
737 | </ccr:Type>
|
---|
738 | <ccr:Description>
|
---|
739 | <ccr:Text>Sodium</ccr:Text>
|
---|
740 | <ccr:Code>
|
---|
741 | <ccr:Value>2951-2</ccr:Value>
|
---|
742 | <ccr:CodingSystem>LOINC</ccr:CodingSystem>
|
---|
743 | </ccr:Code>
|
---|
744 | </ccr:Description>
|
---|
745 | <ccr:Source>
|
---|
746 | <ccr:Actor>
|
---|
747 | <ccr:ActorID>AuthorID_01</ccr:ActorID>
|
---|
748 | </ccr:Actor>
|
---|
749 | </ccr:Source>
|
---|
750 | <ccr:Test>
|
---|
751 | <ccr:CCRDataObjectID/>
|
---|
752 | <ccr:Description>
|
---|
753 | <ccr:Text>Sodium</ccr:Text>
|
---|
754 | <ccr:Code>
|
---|
755 | <ccr:Value>2951-2</ccr:Value>
|
---|
756 | <ccr:CodingSystem>LOINC</ccr:CodingSystem>
|
---|
757 | </ccr:Code>
|
---|
758 | </ccr:Description>
|
---|
759 | <ccr:Status>
|
---|
760 | <ccr:Text>final result</ccr:Text>
|
---|
761 | </ccr:Status>
|
---|
762 | <ccr:Source/>
|
---|
763 | <ccr:TestResult>
|
---|
764 | <ccr:Value>141</ccr:Value>
|
---|
765 | <ccr:Units>
|
---|
766 | <ccr:Unit>mEq/L</ccr:Unit>
|
---|
767 | </ccr:Units>
|
---|
768 | </ccr:TestResult>
|
---|
769 | <ccr:NormalResult>
|
---|
770 | <ccr:Normal>
|
---|
771 | <ccr:Value>135-146</ccr:Value>
|
---|
772 | <ccr:Units>
|
---|
773 | <ccr:Unit>mEq/L</ccr:Unit>
|
---|
774 | </ccr:Units>
|
---|
775 | <ccr:Source/>
|
---|
776 | </ccr:Normal>
|
---|
777 | </ccr:NormalResult>
|
---|
778 | </ccr:Test>
|
---|
779 | </ccr:Result>
|
---|
780 |
|
---|
781 | <ccr:Result>
|
---|
782 | <ccr:CCRDataObjectID>ResultID_05</ccr:CCRDataObjectID>
|
---|
783 | <ccr:DateTime>
|
---|
784 | <ccr:ApproximateDateTime>
|
---|
785 | <ccr:Text>9/16/09</ccr:Text>
|
---|
786 | </ccr:ApproximateDateTime>
|
---|
787 | </ccr:DateTime>
|
---|
788 | <ccr:Type>
|
---|
789 | <ccr:Text>Chemistry</ccr:Text>
|
---|
790 | </ccr:Type>
|
---|
791 | <ccr:Description>
|
---|
792 | <ccr:Text>Total cholesterol</ccr:Text>
|
---|
793 | <ccr:Code>
|
---|
794 | <ccr:Value>14647-2</ccr:Value>
|
---|
795 | <ccr:CodingSystem>LOINC</ccr:CodingSystem>
|
---|
796 | </ccr:Code>
|
---|
797 | </ccr:Description>
|
---|
798 | <ccr:Source>
|
---|
799 | <ccr:Actor>
|
---|
800 | <ccr:ActorID>AuthorID_01</ccr:ActorID>
|
---|
801 | </ccr:Actor>
|
---|
802 | </ccr:Source>
|
---|
803 | <ccr:Test>
|
---|
804 | <ccr:CCRDataObjectID/>
|
---|
805 | <ccr:Description>
|
---|
806 | <ccr:Text>Total cholesterol</ccr:Text>
|
---|
807 | <ccr:Code>
|
---|
808 | <ccr:Value>14647-2</ccr:Value>
|
---|
809 | <ccr:CodingSystem>LOINC</ccr:CodingSystem>
|
---|
810 | </ccr:Code>
|
---|
811 | </ccr:Description>
|
---|
812 | <ccr:Status>
|
---|
813 | <ccr:Text>final result</ccr:Text>
|
---|
814 | </ccr:Status>
|
---|
815 | <ccr:Source/>
|
---|
816 | <ccr:TestResult>
|
---|
817 | <ccr:Value>162</ccr:Value>
|
---|
818 | <ccr:Units>
|
---|
819 | <ccr:Unit>mg/dl</ccr:Unit>
|
---|
820 | </ccr:Units>
|
---|
821 | </ccr:TestResult>
|
---|
822 | <ccr:NormalResult>
|
---|
823 | <ccr:Normal>
|
---|
824 | <ccr:Value>< 200</ccr:Value>
|
---|
825 | <ccr:Units>
|
---|
826 | <ccr:Unit>mg/dl</ccr:Unit>
|
---|
827 | </ccr:Units>
|
---|
828 | <ccr:Source/>
|
---|
829 | </ccr:Normal>
|
---|
830 | </ccr:NormalResult>
|
---|
831 | </ccr:Test>
|
---|
832 | </ccr:Result>
|
---|
833 |
|
---|
834 | <ccr:Result>
|
---|
835 | <ccr:CCRDataObjectID>ResultID_06</ccr:CCRDataObjectID>
|
---|
836 | <ccr:DateTime>
|
---|
837 | <ccr:ApproximateDateTime>
|
---|
838 | <ccr:Text>9/16/09</ccr:Text>
|
---|
839 | </ccr:ApproximateDateTime>
|
---|
840 | </ccr:DateTime>
|
---|
841 | <ccr:Type>
|
---|
842 | <ccr:Text>Chemistry</ccr:Text>
|
---|
843 | </ccr:Type>
|
---|
844 | <ccr:Description>
|
---|
845 | <ccr:Text>HDL cholesterol</ccr:Text>
|
---|
846 | <ccr:Code>
|
---|
847 | <ccr:Value>14646-4</ccr:Value>
|
---|
848 | <ccr:CodingSystem>LOINC</ccr:CodingSystem>
|
---|
849 | </ccr:Code>
|
---|
850 | </ccr:Description>
|
---|
851 | <ccr:Source>
|
---|
852 | <ccr:Actor>
|
---|
853 | <ccr:ActorID>AuthorID_01</ccr:ActorID>
|
---|
854 | </ccr:Actor>
|
---|
855 | </ccr:Source>
|
---|
856 | <ccr:Test>
|
---|
857 | <ccr:CCRDataObjectID/>
|
---|
858 | <ccr:Description>
|
---|
859 | <ccr:Text>HDL cholesterol</ccr:Text>
|
---|
860 | <ccr:Code>
|
---|
861 | <ccr:Value>14646-4</ccr:Value>
|
---|
862 | <ccr:CodingSystem>LOINC</ccr:CodingSystem>
|
---|
863 | </ccr:Code>
|
---|
864 | </ccr:Description>
|
---|
865 | <ccr:Status>
|
---|
866 | <ccr:Text>final result</ccr:Text>
|
---|
867 | </ccr:Status>
|
---|
868 | <ccr:Source/>
|
---|
869 | <ccr:TestResult>
|
---|
870 | <ccr:Value>43</ccr:Value>
|
---|
871 | <ccr:Units>
|
---|
872 | <ccr:Unit>mg/dl</ccr:Unit>
|
---|
873 | </ccr:Units>
|
---|
874 | </ccr:TestResult>
|
---|
875 | <ccr:NormalResult>
|
---|
876 | <ccr:Normal>
|
---|
877 | <ccr:Value>> 40</ccr:Value>
|
---|
878 | <ccr:Units>
|
---|
879 | <ccr:Unit>mg/dl</ccr:Unit>
|
---|
880 | </ccr:Units>
|
---|
881 | <ccr:Source/>
|
---|
882 | </ccr:Normal>
|
---|
883 | </ccr:NormalResult>
|
---|
884 | </ccr:Test>
|
---|
885 | </ccr:Result>
|
---|
886 |
|
---|
887 | <ccr:Result>
|
---|
888 | <ccr:CCRDataObjectID>ResultID_07</ccr:CCRDataObjectID>
|
---|
889 | <ccr:DateTime>
|
---|
890 | <ccr:ApproximateDateTime>
|
---|
891 | <ccr:Text>9/16/09</ccr:Text>
|
---|
892 | </ccr:ApproximateDateTime>
|
---|
893 | </ccr:DateTime>
|
---|
894 | <ccr:Type>
|
---|
895 | <ccr:Text>Chemistry</ccr:Text>
|
---|
896 | </ccr:Type>
|
---|
897 | <ccr:Description>
|
---|
898 | <ccr:Text>LDL cholesterol</ccr:Text>
|
---|
899 | <ccr:Code>
|
---|
900 | <ccr:Value>2089-1</ccr:Value>
|
---|
901 | <ccr:CodingSystem>LOINC</ccr:CodingSystem>
|
---|
902 | </ccr:Code>
|
---|
903 | </ccr:Description>
|
---|
904 | <ccr:Source>
|
---|
905 | <ccr:Actor>
|
---|
906 | <ccr:ActorID>AuthorID_01</ccr:ActorID>
|
---|
907 | </ccr:Actor>
|
---|
908 | </ccr:Source>
|
---|
909 | <ccr:Test>
|
---|
910 | <ccr:CCRDataObjectID/>
|
---|
911 | <ccr:Description>
|
---|
912 | <ccr:Text>LDL cholesterol</ccr:Text>
|
---|
913 | <ccr:Code>
|
---|
914 | <ccr:Value>2089-1</ccr:Value>
|
---|
915 | <ccr:CodingSystem>LOINC</ccr:CodingSystem>
|
---|
916 | </ccr:Code>
|
---|
917 | </ccr:Description>
|
---|
918 | <ccr:Status>
|
---|
919 | <ccr:Text>final result</ccr:Text>
|
---|
920 | </ccr:Status>
|
---|
921 | <ccr:Source/>
|
---|
922 | <ccr:TestResult>
|
---|
923 | <ccr:Value>84</ccr:Value>
|
---|
924 | <ccr:Units>
|
---|
925 | <ccr:Unit>mg/dl</ccr:Unit>
|
---|
926 | </ccr:Units>
|
---|
927 | </ccr:TestResult>
|
---|
928 | <ccr:NormalResult>
|
---|
929 | <ccr:Normal>
|
---|
930 | <ccr:Value>< 100</ccr:Value>
|
---|
931 | <ccr:Units>
|
---|
932 | <ccr:Unit>mg/dl</ccr:Unit>
|
---|
933 | </ccr:Units>
|
---|
934 | <ccr:Source/>
|
---|
935 | </ccr:Normal>
|
---|
936 | </ccr:NormalResult>
|
---|
937 | </ccr:Test>
|
---|
938 | </ccr:Result>
|
---|
939 |
|
---|
940 | <ccr:Result>
|
---|
941 | <ccr:CCRDataObjectID>ResultID_08</ccr:CCRDataObjectID>
|
---|
942 | <ccr:DateTime>
|
---|
943 | <ccr:ApproximateDateTime>
|
---|
944 | <ccr:Text>9/16/09</ccr:Text>
|
---|
945 | </ccr:ApproximateDateTime>
|
---|
946 | </ccr:DateTime>
|
---|
947 | <ccr:Type>
|
---|
948 | <ccr:Text>Chemistry</ccr:Text>
|
---|
949 | </ccr:Type>
|
---|
950 | <ccr:Description>
|
---|
951 | <ccr:Text>Triglycerides</ccr:Text>
|
---|
952 | <ccr:Code>
|
---|
953 | <ccr:Value>14927-8</ccr:Value>
|
---|
954 | <ccr:CodingSystem>LOINC</ccr:CodingSystem>
|
---|
955 | </ccr:Code>
|
---|
956 | </ccr:Description>
|
---|
957 | <ccr:Source>
|
---|
958 | <ccr:Actor>
|
---|
959 | <ccr:ActorID>AuthorID_01</ccr:ActorID>
|
---|
960 | </ccr:Actor>
|
---|
961 | </ccr:Source>
|
---|
962 | <ccr:Test>
|
---|
963 | <ccr:CCRDataObjectID/>
|
---|
964 | <ccr:Description>
|
---|
965 | <ccr:Text>Triglycerides</ccr:Text>
|
---|
966 | <ccr:Code>
|
---|
967 | <ccr:Value>14927-8</ccr:Value>
|
---|
968 | <ccr:CodingSystem>LOINC</ccr:CodingSystem>
|
---|
969 | </ccr:Code>
|
---|
970 | </ccr:Description>
|
---|
971 | <ccr:Status>
|
---|
972 | <ccr:Text>final result</ccr:Text>
|
---|
973 | </ccr:Status>
|
---|
974 | <ccr:Source/>
|
---|
975 | <ccr:TestResult>
|
---|
976 | <ccr:Value>177</ccr:Value>
|
---|
977 | <ccr:Units>
|
---|
978 | <ccr:Unit>mg/dl</ccr:Unit>
|
---|
979 | </ccr:Units>
|
---|
980 | </ccr:TestResult>
|
---|
981 | <ccr:NormalResult>
|
---|
982 | <ccr:Normal>
|
---|
983 | <ccr:Value>< 150</ccr:Value>
|
---|
984 | <ccr:Units>
|
---|
985 | <ccr:Unit>mg/dl</ccr:Unit>
|
---|
986 | </ccr:Units>
|
---|
987 | <ccr:Source/>
|
---|
988 | </ccr:Normal>
|
---|
989 | </ccr:NormalResult>
|
---|
990 | </ccr:Test>
|
---|
991 | </ccr:Result>
|
---|
992 | </ccr:Results>
|
---|
993 |
|
---|
994 |
|
---|
995 | <ccr:Procedures>
|
---|
996 | <ccr:Procedure>
|
---|
997 | <ccr:CCRDataObjectID>ProcID_1</ccr:CCRDataObjectID>
|
---|
998 | <ccr:DateTime>
|
---|
999 | <ccr:ApproximateDateTime>
|
---|
1000 | <ccr:Text>7/26/06</ccr:Text>
|
---|
1001 | </ccr:ApproximateDateTime>
|
---|
1002 | </ccr:DateTime>
|
---|
1003 | <ccr:Type>
|
---|
1004 | <ccr:Text>Surgical</ccr:Text>
|
---|
1005 | </ccr:Type>
|
---|
1006 | <ccr:Description>
|
---|
1007 | <ccr:Text>Excision of benign lesion on arm</ccr:Text>
|
---|
1008 | <ccr:Code>
|
---|
1009 | <ccr:Value>11401</ccr:Value>
|
---|
1010 | <ccr:CodingSystem>CPT-4</ccr:CodingSystem>
|
---|
1011 | </ccr:Code>
|
---|
1012 | <ccr:Code>
|
---|
1013 | <ccr:Value>86.3</ccr:Value>
|
---|
1014 | <ccr:CodingSystem>ICD-9</ccr:CodingSystem>
|
---|
1015 | </ccr:Code>
|
---|
1016 | </ccr:Description>
|
---|
1017 | <ccr:Status>
|
---|
1018 | <ccr:Text>Completed</ccr:Text>
|
---|
1019 | </ccr:Status>
|
---|
1020 | <ccr:Source>
|
---|
1021 | <ccr:Actor>
|
---|
1022 | <ccr:ActorID>AuthorID_01</ccr:ActorID>
|
---|
1023 | </ccr:Actor>
|
---|
1024 | </ccr:Source>
|
---|
1025 | <ccr:Locations>
|
---|
1026 | <ccr:Location>
|
---|
1027 | <ccr:Actor>
|
---|
1028 | <ccr:ActorID>ClinicID_01</ccr:ActorID>
|
---|
1029 | </ccr:Actor>
|
---|
1030 | </ccr:Location>
|
---|
1031 | </ccr:Locations>
|
---|
1032 | <ccr:Substance>
|
---|
1033 | <ccr:Text>NA</ccr:Text>
|
---|
1034 | </ccr:Substance>
|
---|
1035 | <ccr:Method>
|
---|
1036 | <ccr:Text>NA</ccr:Text>
|
---|
1037 | </ccr:Method>
|
---|
1038 | <ccr:Position>
|
---|
1039 | <ccr:Text>NA</ccr:Text>
|
---|
1040 | </ccr:Position>
|
---|
1041 | <ccr:Site>
|
---|
1042 | <ccr:Text>Left Arm</ccr:Text>
|
---|
1043 | </ccr:Site>
|
---|
1044 | </ccr:Procedure>
|
---|
1045 |
|
---|
1046 | <ccr:Procedure>
|
---|
1047 | <ccr:CCRDataObjectID>ProcID_2</ccr:CCRDataObjectID>
|
---|
1048 | <ccr:DateTime>
|
---|
1049 | <ccr:ApproximateDateTime>
|
---|
1050 | <ccr:Text>05/15/03</ccr:Text>
|
---|
1051 | </ccr:ApproximateDateTime>
|
---|
1052 | </ccr:DateTime>
|
---|
1053 | <ccr:Type>
|
---|
1054 | <ccr:Text>Surgical</ccr:Text>
|
---|
1055 | </ccr:Type>
|
---|
1056 | <ccr:Description>
|
---|
1057 | <ccr:Text>Emergency Appendectomy</ccr:Text>
|
---|
1058 | <ccr:Code>
|
---|
1059 | <ccr:Value>44950</ccr:Value>
|
---|
1060 | <ccr:CodingSystem>CPT-4</ccr:CodingSystem>
|
---|
1061 | </ccr:Code>
|
---|
1062 | <ccr:Code>
|
---|
1063 | <ccr:Value>47.09</ccr:Value>
|
---|
1064 | <ccr:CodingSystem>ICD-9</ccr:CodingSystem>
|
---|
1065 | </ccr:Code>
|
---|
1066 | </ccr:Description>
|
---|
1067 | <ccr:Status>
|
---|
1068 | <ccr:Text>Completed</ccr:Text>
|
---|
1069 | </ccr:Status>
|
---|
1070 | <ccr:Source>
|
---|
1071 | <ccr:Actor>
|
---|
1072 | <ccr:ActorID>AuthorID_01</ccr:ActorID>
|
---|
1073 | </ccr:Actor>
|
---|
1074 | </ccr:Source>
|
---|
1075 | <ccr:Locations>
|
---|
1076 | <ccr:Location>
|
---|
1077 | <ccr:Actor>
|
---|
1078 | <ccr:ActorID>ClinicID_01</ccr:ActorID>
|
---|
1079 | </ccr:Actor>
|
---|
1080 | </ccr:Location>
|
---|
1081 | </ccr:Locations>
|
---|
1082 | <ccr:Substance>
|
---|
1083 | <ccr:Text>NA</ccr:Text>
|
---|
1084 | </ccr:Substance>
|
---|
1085 | <ccr:Method>
|
---|
1086 | <ccr:Text>NA</ccr:Text>
|
---|
1087 | </ccr:Method>
|
---|
1088 | <ccr:Position>
|
---|
1089 | <ccr:Text>NA</ccr:Text>
|
---|
1090 | </ccr:Position>
|
---|
1091 | <ccr:Site>
|
---|
1092 | <ccr:Text>NA</ccr:Text>
|
---|
1093 | </ccr:Site>
|
---|
1094 | </ccr:Procedure>
|
---|
1095 | </ccr:Procedures>
|
---|
1096 | </ccr:Body>
|
---|
1097 | <ccr:Actors>
|
---|
1098 | <ccr:Actor>
|
---|
1099 | <ccr:ActorObjectID>PatientID_1</ccr:ActorObjectID>
|
---|
1100 | <ccr:Person>
|
---|
1101 | <ccr:Name>
|
---|
1102 | <ccr:BirthName>
|
---|
1103 | <ccr:Given>Jeffrey</ccr:Given>
|
---|
1104 | <ccr:Given></ccr:Given>
|
---|
1105 | <ccr:Family>Surrett</ccr:Family>
|
---|
1106 | </ccr:BirthName>
|
---|
1107 | </ccr:Name>
|
---|
1108 | <ccr:DateOfBirth>
|
---|
1109 | <ccr:ExactDateTime>1960-09-24T11:20:00-05:00</ccr:ExactDateTime>
|
---|
1110 | </ccr:DateOfBirth>
|
---|
1111 | <ccr:Gender>
|
---|
1112 | <ccr:Text>Male</ccr:Text>
|
---|
1113 | <ccr:Code>
|
---|
1114 | <ccr:Value>M</ccr:Value>
|
---|
1115 | <ccr:CodingSystem>HL7 AdministrativeGender</ccr:CodingSystem>
|
---|
1116 | </ccr:Code>
|
---|
1117 | </ccr:Gender>
|
---|
1118 | </ccr:Person>
|
---|
1119 | <ccr:IDs>
|
---|
1120 | <ccr:ID>999869999</ccr:ID>
|
---|
1121 | <ccr:IssuedBy>
|
---|
1122 | <ccr:ActorID>ClinicID_01</ccr:ActorID>
|
---|
1123 | <ccr:ActorRole>
|
---|
1124 | <ccr:Text>Medical Record Number</ccr:Text>
|
---|
1125 | </ccr:ActorRole>
|
---|
1126 | </ccr:IssuedBy>
|
---|
1127 | <ccr:Source/>
|
---|
1128 | </ccr:IDs>
|
---|
1129 | <ccr:Address>
|
---|
1130 | <ccr:Line1>347 Grove Street</ccr:Line1>
|
---|
1131 | <ccr:City>Williamsport</ccr:City>
|
---|
1132 | <ccr:State>PA</ccr:State>
|
---|
1133 | <ccr:PostalCode>17701</ccr:PostalCode>
|
---|
1134 | </ccr:Address>
|
---|
1135 | <ccr:Telephone>
|
---|
1136 | <ccr:Value>+1-570-837-9933</ccr:Value>
|
---|
1137 | </ccr:Telephone>
|
---|
1138 | <ccr:Source/>
|
---|
1139 | </ccr:Actor>
|
---|
1140 | <ccr:Actor>
|
---|
1141 | <ccr:ActorObjectID>AuthorID_01</ccr:ActorObjectID>
|
---|
1142 | <ccr:Person>
|
---|
1143 | <ccr:Name>
|
---|
1144 | <ccr:BirthName>
|
---|
1145 | <ccr:Given>Thomas</ccr:Given>
|
---|
1146 | <ccr:Family>Henry</ccr:Family>
|
---|
1147 | <ccr:Suffix>MD</ccr:Suffix>
|
---|
1148 | </ccr:BirthName>
|
---|
1149 | </ccr:Name>
|
---|
1150 | </ccr:Person>
|
---|
1151 | <ccr:Address>
|
---|
1152 | <ccr:Line1>5544 Sutter Street</ccr:Line1>
|
---|
1153 | <ccr:City>Williamsport</ccr:City>
|
---|
1154 | <ccr:State>PA</ccr:State>
|
---|
1155 | <ccr:PostalCode>17701</ccr:PostalCode>
|
---|
1156 | </ccr:Address>
|
---|
1157 | <ccr:Telephone>
|
---|
1158 | <ccr:Value>+1-301-975-3260</ccr:Value>
|
---|
1159 | </ccr:Telephone>
|
---|
1160 | <ccr:Source/>
|
---|
1161 | </ccr:Actor>
|
---|
1162 | <ccr:Actor>
|
---|
1163 | <ccr:ActorObjectID>RecipientID_01</ccr:ActorObjectID>
|
---|
1164 | <ccr:Person>
|
---|
1165 | <ccr:Name>
|
---|
1166 | <ccr:BirthName>
|
---|
1167 | <ccr:Given>Interested</ccr:Given>
|
---|
1168 | <ccr:Family>AnyPerson</ccr:Family>
|
---|
1169 | </ccr:BirthName>
|
---|
1170 | </ccr:Name>
|
---|
1171 | </ccr:Person>
|
---|
1172 | <ccr:Source/>
|
---|
1173 | </ccr:Actor>
|
---|
1174 | <ccr:Actor>
|
---|
1175 | <ccr:ActorObjectID>ManufID_1</ccr:ActorObjectID>
|
---|
1176 | <ccr:Organization>
|
---|
1177 | <ccr:Name>GLAXOSMITHKLINE</ccr:Name>
|
---|
1178 | </ccr:Organization>
|
---|
1179 | <ccr:Source/>
|
---|
1180 | </ccr:Actor>
|
---|
1181 | <ccr:Actor>
|
---|
1182 | <ccr:ActorObjectID>ManufID_2</ccr:ActorObjectID>
|
---|
1183 | <ccr:Organization>
|
---|
1184 | <ccr:Name>Merck</ccr:Name>
|
---|
1185 | </ccr:Organization>
|
---|
1186 | <ccr:Source/>
|
---|
1187 | </ccr:Actor>
|
---|
1188 | <ccr:Actor>
|
---|
1189 | <ccr:ActorObjectID>ClinicID_01</ccr:ActorObjectID>
|
---|
1190 | <ccr:Organization>
|
---|
1191 | <ccr:Name>Metropolitan Clinic</ccr:Name>
|
---|
1192 | </ccr:Organization>
|
---|
1193 | <ccr:Address>
|
---|
1194 | <ccr:Line1>5544 Sutter Street</ccr:Line1>
|
---|
1195 | <ccr:City>Williamsport</ccr:City>
|
---|
1196 | <ccr:State>PA</ccr:State>
|
---|
1197 | <ccr:PostalCode>17701</ccr:PostalCode>
|
---|
1198 | </ccr:Address>
|
---|
1199 | <ccr:Source/>
|
---|
1200 | </ccr:Actor>
|
---|
1201 | </ccr:Actors>
|
---|
1202 | </ccr:ContinuityOfCareRecord>
|
---|